Keywords: protherics, sells, camd, tularik, uk, biopharmaceutical, company
Protherics sells CAMD to Tularik
Article | 13 July 2001
UK biopharmaceutical company Protherics is selling its Computer-AidedMolecule Design operations to Tularik, a San Francisco, USA-based drug discovery company, for 400,000 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
